Summer 2027 MBA Interns | Business Leadership Development Program (BuiLD)
Regeneron Pharmaceuticals
Summary
We are seeking 1st Year MBA students who are passionate about science and the business of biotechnology to join Regeneron's MBA Summer internship program. Opportunities are available in the following areas: Corporate Strategy, Business Development, Market Access Strategy, New Products, Rare Disease Marketing.
Job description
In this role, a typical internship experience might include the following:
- Working on meaningful, high-impact projects
- Gaining exposure to senior leadership through Lunch & Learns and other events
- Presenting a final project to senior leaders including the BuiLD board
- Participating in team building and other fun events with the BuiLD community
- Experiencing Regeneron's amazing culture firsthand
- Collaborating, learning, and growing from a world-class organization
This Role Might Be For You If
- You are a self-starter with an entrepreneurial spirit
- You are passionate about Regeneron's mission of science to medicine
- You can execute in a cross-functional environment
- You possess strong project management skills
- You have proven leadership skills in previous roles
- You have strong problem-solving skills with the ability to think through complex business problems and propose a path toward arriving at a solution
- You have integrity and a dedication to high ethical standards
Requirements
- Enrolled in a distinguished MBA program
- First-year MBA student
- Anticipating graduating in the Spring/Summer of 2028
- Self-starter with an entrepreneurial spirit
- Passionate about science and the business of biotechnology
- Ability to execute in a cross-functional environment
- Strong project management skills
- Proven leadership skills in previous roles
- Strong problem-solving skills
- Integrity and dedication to high ethical standards
- Experience in biotech, biotech consulting, or biotech investing is preferred
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension or Retirement Benefits
- 401(k) Company Match
- Health and Wellness Programs
- Fitness Centers
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.